Relx (NYSE:RELX) Upgraded at StockNews.com

StockNews.com upgraded shares of Relx (NYSE:RELX) from a hold rating to a buy rating in a research report report published on Friday.

Separately, Redburn Atlantic began coverage on shares of Relx in a report on Wednesday, January 8th. They set a “buy” rating on the stock.

Relx Price Performance

Shares of Relx stock opened at $51.14 on Friday. The company has a current ratio of 0.48, a quick ratio of 0.42 and a debt-to-equity ratio of 1.63. Relx has a 1 year low of $40.25 and a 1 year high of $51.99. The firm’s 50-day moving average is $47.81 and its two-hundred day moving average is $47.15.

Institutional Trading of Relx

Institutional investors have recently modified their holdings of the company. CENTRAL TRUST Co boosted its holdings in shares of Relx by 1,290.2% in the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock valued at $26,000 after buying an additional 529 shares in the last quarter. Versant Capital Management Inc acquired a new stake in Relx in the 4th quarter worth approximately $31,000. Transce3nd LLC acquired a new stake in Relx in the 4th quarter worth approximately $40,000. Sierra Ocean LLC acquired a new stake in Relx in the 4th quarter worth approximately $43,000. Finally, Brown Brothers Harriman & Co. boosted its stake in Relx by 218.5% in the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company’s stock worth $44,000 after purchasing an additional 662 shares in the last quarter. 15.02% of the stock is currently owned by institutional investors.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.